Press release
Point of Care Diagnostics Market Forecast to Grow at 6.1% CAGR from 2024 to 2031 | SkyQuest Technology
Point Of Care Diagnostics Market Size, Share, Growth Analysis, By Sample(Blood Samples, Urine Samples, Nasal & Oropharyngeal Swabs, and Other Samples), By Product Type(Glucose Monitoring Products (Strips, Meters, Lancets & Lancing Devices), Covid-19 Testing Products), By End-Users(Clinical Laboratories, Ambulatory Care Facilities and Physicians Offices, Pharmacies, Retail Clinics), By Region - Industry Forecast 2024-2031Point of Care Diagnostics Market [https://www.skyquestt.com/report/point-of-care-diagnostics-market] size was valued at USD 47.64 Billion in 2022 and is poised to grow from USD 50.54 Billion in 2023 to USD 81.17 Billion by 2031, at a CAGR of 6.1% during the forecast period (2024-2031).
The medical devices that are used for getting immediate results while examining or monitoring different diseases like cancer, diabetes, heart issues come under point-of-care diagnostics (POCD). The necessity to make medical sector more patient-centered is positively influencing the growth of POCD market. POCD has dramatically transformed the patient care system with its competency and simplicity. Point-of-care diagnostics technologies have developed because of enhancement in the area of microfluids. In the last few years, microfabrication and microfluids process have evolved so much that now POC devices have become more affordable, easy to use, portable, and provide faster results. There are many factors that are influencing the growth of the market like development of handheld devices, biosensors, and advanced connectivity features. New technology like lab-on-a-chip is also contributing the growth by enhancing speed, accessibility to the POC tests, and better preciseness.
Download a detailed overview:
https://www.skyquestt.com/sample-request/point-of-care-diagnostics-market
Increasing Cases of Chronic and Infectious Diseases Drives the Market
There has been a massive rise in the occurrence of chronic diseases like cardiovascular issues, diabetes, and several infectious illnesses worldwide. One of the key factors boosting the demand for the POCD market is the rise of the such chronic diseases. As per United Nations, almost 38 million people were suffering from HIV/AIDS in 2019. There were nearly 1.8 million youngsters and 36.2 million adults. Furthermore, the rise of human respiratory syncytial virus (RSV), a common virus responsible for respiratory tract contamination is also boosting the growth of the POCD market. An increase in the cases of diabetes and chronic illnesses has created demand for care diagnosis with the objective of managing it efficiently and offering better results.
Technological Developments in the POCD to Improve Market
Key market players are now focusing on the utilization of latest technologies like artificial intelligence for the manufacturing for effective point of care diagnostics. One of the popular device and technologies that is positively impact the market are lab-on-a-chip platform wearable technology used for detecting infectious illness and help to monitor a patient's health and provide better testing. As cloud-based intelligent have provided numerous possibilities to improve the devices will mark the way for many advancements. The development of new diagnostics system has also been influenced by technologies like innovative biosensors, miniaturization in chips, and microfluids. Today, it is also possible to implement solutions like microbiological culture, polymerase chain reaction (PCR), enzyme-linked immunosorbent assays (ELISA) in the point-of-care due to technologies like lab-on-a-chip, driving the market growth.
Request Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/point-of-care-diagnostics-market
* In October 2023, QIAGEN get the CE certification of their IVD kit and automated testing platform.
* In May 2023, Danaher Corporation introduced the Dxl 9000 Access Immunoassay Analyzer. This device can run almost 215 tests per hour, expanding POC diagnostics offerings.
* In February 2024, Roche Diagnostics revealed that it had got the CE market approval for the extension of its Elecsys Anti-Mullerian Hormone (AMH) Plus immunoassay.
* In March 2023, F. Hoffman Roche Ltd. Collaborated with Eli Lilly to develop Elecsys Amyloid Plasma Panel (EAPP). This alliance will help the companies to target a crucial area of unmet medical requirement.
View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/point-of-care-diagnostics-market
The usage of POCD devices will increase with the rise in diagnostic procedures for diseases and advanced applications. Notable technological advancements in the POC diagnostics devices will provide innovative diagnosis options for monitoring diseases like diabetes cardiac diseases, and cancer. Nowadays, healthcare providers are also focusing more on these devices because they can easily use them to detect variousillness, monitor patients, and provide better treatment. Rise in infectious diseases, technological developments, and focus on early prevention are some of the important factors driving the market. Additionally, more POC diagnostics device manufacturers and distributers are emphasizing on the emerging markets as rapid growth was witnessed in the shipments of these devices to offer enhanced healthcare services in developing countries. This in turn is expanding the growth of the global POC diagnostics market.
Related Reports:
Cloud Computing Market [https://www.skyquestt.com/report/cloud-computing-market]
Visit Our Website: https://www.skyquestt.com/
Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=point-of-care-diagnostics-market-forecast-to-grow-at-61-cagr-from-2024-to-2031-skyquest-technology]
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/point-of-care-diagnostics-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Point of Care Diagnostics Market Forecast to Grow at 6.1% CAGR from 2024 to 2031 | SkyQuest Technology here
News-ID: 3590521 • Views: …
More Releases from ABNewswire

How to Pick the Best Online Chemistry Tutoring Platform
Image: https://www.abnewswire.com/upload/2025/10/814f4b38d9855ce5fcc0509bfebaa240.jpg
Choosing the right chemistry tutoring platform can make the difference between academic success and continued struggles with complex reactions and molecular structures. With students increasingly turning to digital solutions for personalized learning support, the online chemistry tutoring market has exploded with options promising everything from AI-powered progress tracking to virtual lab experiences that transform how learners approach this challenging subject.
Essential Platform Features for Effective Online Chemistry Tutoring
Modern chemistry tutoring…

Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious…

Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical De …
DelveInsight's, "Diabetic Retinopathy Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Retinopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by…

Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Macular Edema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our…
More Releases for POC
Primary Catalyst Driving POC Medical Imaging Market Evolution in 2025: Chronic D …
What market dynamics are playing a key role in accelerating the growth of the poc medical imaging market?
The escalating occurrence of long-term diseases is predicted to boost the expansion of the point-of-care medical imaging market in the future. The chronic disease prevalence pertains to the fraction or the count of people in a community affected by enduring health ailments at any given moment. This transition originates from lifestyle options, inherited…
Transforming the Point-of-Care (POC) Coagulation Testing Market in 2025: Cardiov …
"What Is the Expected Size and Growth Rate of the Point-of-Care (POC) Coagulation Testing Market?
The point-of-care (POC) coagulation testing market has grown significantly in recent years. It will grow from $1.18 billion in 2024 to $1.25 billion in 2025, at a CAGR of 5.8%. The growth is driven by increasing patient demand, the growing trend of point-of-care testing, high reliability in coagulation status testing, automation, integration with electronic health records…
POC Diagnostic Testing Devices | 1drop
1drop Inc.'s POC diagnostic testing devices are essential tools in modern healthcare, designed to deliver quick and accurate results for various health conditions at the point of care. These devices make diagnostics more accessible and timelier, enhancing healthcare delivery and patient outcomes.
Point-of-Care Molecular Diagnostic Platform
1drop offers a comprehensive POC molecular diagnostic platform that consists of three main components:
• Reagent: Specialized reagents formulated for specific tests, including molecular diagnostics.
• Device: The 1POT™ Duo…
POC Diagnostics Market Size 2024 to 2031.
Market Overview and Report Coverage
POC, or Point of Care, Diagnostics refer to medical tests that are performed outside of a traditional laboratory setting, allowing for quicker results and immediate treatment decisions. The POC Diagnostics Market encompasses a wide range of diagnostic tests including blood glucose monitoring, pregnancy tests, infectious disease testing, and more.
The future outlook of the POC Diagnostics Market is optimistic, with the market expected to grow…
Point of Care (POC) Coagulation Testing Devices Market - Transforming Coagulatio …
Newark, New Castle, USA: The "Point of Care (POC) Coagulation Testing Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Point of Care (POC) Coagulation Testing Devices…
POC Cardiovascular Diagnostic Market 2022 | Detailed Report
According to Market Study Report, POC Cardiovascular Diagnostic Market provides a comprehensive analysis of the POC Cardiovascular Diagnostic Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5467652
The report provides a comprehensive analysis of company profiles listed below:
- Abbott
- Biomerieux
- Danaher
- F.…